# Avista Pharma Solutions, Inc., Agawam, MA – FDA Inspections

Source: https://www.keypedia.com/companies/avista-pharma-solutions-inc/abe58c04-c144-4601-a4df-a290928bafa5

> Inspection records and compliance data for Avista Pharma Solutions, Inc. in Agawam, Massachusetts. 7 FDA inspections on record, 2 Form 483s, last inspected August 14, 2026.

---

## Details

- Name: Avista Pharma Solutions, Inc.
- FEI Number: 1220785
- Business Operations: API/FDF ANALYTICAL TESTING
- Address Line 1: 104 Gold St
- City: Agawam
- State: Massachusetts
- Zip Code: 01001
- Country Name: United States
- Address: 104 Gold St, Agawam, Massachusetts 01001, United States
- Country: United States

## Related Documents

- [FDA Inspection 1332618 - Avista Pharma Solutions, Inc. - 2026-08-14](https://www.keypedia.com/records/fda_inspections/avista-pharma-solutions-inc/5ddb9995-7883-41bf-b5d3-71b14a2b65d2) — source: FDA, date: August 14, 2026
- [EIR - Avista Pharma Solutions, Inc. - 2025-07-25](https://www.keypedia.com/records/eir/avista-pharma-solutions-inc/a94e807f-a60a-40fd-b66f-102c3a957832) — source: FDA, date: July 25, 2025
- [483 - Avista Pharma Solutions, Inc. - 2025-07-25](https://www.keypedia.com/records/483/avista-pharma-solutions-inc/dda545e9-7e67-4c8e-a7de-c638725bd84e) — source: FDA, date: July 25, 2025
- [FDA Inspection 1278383 - Avista Pharma Solutions, Inc. - 2025-07-25](https://www.keypedia.com/records/fda_inspections/avista-pharma-solutions-inc/07d264c9-9218-4fc2-92ce-25f1f2348432) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 25, 2025
- [EIR - Avista Pharma Solutions, Inc. - 2019-12-18](https://www.keypedia.com/records/eir/avista-pharma-solutions-inc/d31551c3-16ba-4f4a-aaac-b85e5bf22bcc) — source: FDA, date: December 18, 2019
- [FDA Inspection 1113974 - Avista Pharma Solutions, Inc. - 2019-12-18](https://www.keypedia.com/records/fda_inspections/avista-pharma-solutions-inc/43a50e53-b23a-4132-b1c6-e57509860e23) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 18, 2019
- FDA Inspection 1067530 - Avista Pharma Solutions, Inc. - 2018-09-05 — classification: No Action Indicated (NAI), source: FDA, date: September 5, 2018
- FDA Inspection 988732 - Avista Pharma Solutions, Inc. - 2016-06-15 — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 15, 2016
- [483 - Avista Pharma Solutions, Inc. - 2013-09-27](https://www.keypedia.com/records/483/avista-pharma-solutions-inc/9f9dbbb7-e4b8-44a3-81c1-7d55709ef9c2) — source: FDA, date: September 27, 2013
- [FDA Inspection 850250 - Avista Pharma Solutions, Inc. - 2013-09-27](https://www.keypedia.com/records/fda_inspections/avista-pharma-solutions-inc/51fdbe29-4c8a-4db0-b664-5ef7edf67340) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 27, 2013
- FDA Inspection 696758 - Avista Pharma Solutions, Inc. - 2010-10-27 — classification: No Action Indicated (NAI), source: FDA, date: October 27, 2010

## Related Companies

- [Element Materials Technology Boston - Acton Inc.](https://www.keypedia.com/companies/element-materials-technology-boston-acton-inc/24258d5a-8309-4e67-90f1-adda6124441c)
- [Vimta Labs Limited](https://www.keypedia.com/companies/vimta-labs-limited/74303e4b-f6dc-4ce6-8216-62d716ea8046)
- [PPD Development, L.P.](https://www.keypedia.com/companies/ppd-development-lp/0d495b78-4879-42fc-8887-4e0294e69720)
- [Solaris Pharma Corp](https://www.keypedia.com/companies/solaris-pharma-corp/2730f83a-223f-4ef6-95e1-4e3b069342ce)
- [Element Materials Technology Oakland-Concord](https://www.keypedia.com/companies/element-materials-technology-oakland-concord/30d36985-08bf-4bba-865d-c40e43e3f574)
- [Accu Bio-Chem Laboratories LLC](https://www.keypedia.com/companies/accu-bio-chem-laboratories-llc/5519bf93-f2bf-4a62-9fb5-2fc1a98547b2)
- [Micron Inc](https://www.keypedia.com/companies/micron-inc/a65b7d60-a630-4106-a66e-0871c2852be4)
- [Kappa Laboratories, Inc.](https://www.keypedia.com/companies/kappa-laboratories-inc/f57ed33f-b9d5-485c-a477-8fd51684e2ee)
- [Labcorp Early Development Laboratories, Inc.](https://www.keypedia.com/companies/labcorp-early-development-laboratories-inc/e6487660-cd04-47c4-879b-cc0248eba943)
- [CHARLES RIVER LABORATORIES](https://www.keypedia.com/companies/charles-river-laboratories/079ae978-a3c8-4c11-a1dc-3f036f3f6df0)

## Related Officers

- [Assuring that quality medicines are available to the American public](https://www.keypedia.com/people/maya-m-davis/4180239e-5b21-4f9c-9ff0-6bbe5222f740)
- [Regional Manager](https://www.keypedia.com/people/jonah-s-ufferfilge/6bcd2028-9aca-4704-bd7b-c835874fad9d)
- [Arizona Market President](https://www.keypedia.com/people/john-p-mistler/7b2d423d-46cc-48bd-aa5a-4ae794888060)
- [M.S., Consumer Safety Officer at FDA](https://www.keypedia.com/people/daniel-l-zheng/5e3d993f-654e-4d40-a2c8-69c5e396499f)
- [investigator](https://www.keypedia.com/people/ifechimere-i-okafor/c48399bf-47d9-4562-9130-1e6731eca07d)